Equities

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Actions
  • Price (EUR)0.85
  • Today's Change-0.005 / -0.58%
  • Shares traded1.00k
  • 1 Year change-44.08%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,3792,2442,276
Total Receivables, Net423942527
Total Inventory1,012470432
Prepaid expenses128.9924
Other current assets, total191818
Total current assets3,8443,6833,277
Property, plant & equipment, net437405412
Goodwill, net------
Intangibles, net566061
Long term investments606363
Note receivable - long term------
Other long term assets------
Total assets4,4344,2253,835
LIABILITIES
Accounts payable17715435
Accrued expenses657788
Notes payable/short-term debt000
Current portion long-term debt/capital leases564253
Other current liabilities, total3114537
Total current liabilities330419213
Total long term debt756175
Total debt132103128
Deferred income tax8.447.187.15
Minority interest154134121
Other liabilities, total------
Total liabilities568621417
SHAREHOLDERS EQUITY
Common stock939939939
Additional paid-in capital------
Retained earnings (accumulated deficit)2,9532,6902,484
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(25)(25)(4.51)
Total equity3,8673,6043,418
Total liabilities & shareholders' equity4,4344,2253,835
Total common shares outstanding837837837
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.